Search - tctmd.com

Displaying 61 - 80 of 433

Sort: Relevancy | Date

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

News Daily News

African-American, but Not Hispanic/Latina, Women Have More MIs After Stenting Than White Women

Caitlin E. Cox

April 18, 2019

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

News Conference News ACC 2019

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

Yael L. Maxwell

March 18, 2019

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

Presentation JIM 2019

TALENT: Thin strut sirolimus-eluting stent in all comers population vs Everolimus-eluting stent

Presenter: Giuseppe Tarantini

February 14, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Conference News AHA 2018

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

Todd Neale

November 12, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

Presentation TCT 2018

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Presenter: James B. Hermiller Jr, Hiroki Shiomi

September 25, 2018

News Conference News TCT 2018

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Michael O'Riordan

September 22, 2018

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Todd Neale

September 22, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Shelley Wood

September 22, 2018

Presentation TCT 2018

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Sorin J. Brener

September 22, 2018

Presentation TCT 2018

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

Presenter: Alexandre Abizaid, Didier Carrié, Ariel Roguin

September 21, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Conference News EuroPCR 2018

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

Michael O'Riordan

May 29, 2018

News Conference News EuroPCR 2018

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Michael O'Riordan

May 25, 2018

News Conference News EuroPCR 2018

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Shelley Wood

May 24, 2018

News Industry News

Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease

May 23, 2018

Advertisement

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

African-American, but Not Hispanic/Latina, Women Have More MIs After Stenting Than White Women

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

TALENT: Thin strut sirolimus-eluting stent in all comers population vs Everolimus-eluting stent

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content